Acute Pain Market to Grow Positively at a Paltry CAGR During the Study Period (2020-2034) | Charleston Laboratories, Neumentum, Neurana Pharmaceuticals, expected to boost the market

United States, Nevada, Las Vegas, DelveInsight's "Acute Pain - Market Insight, Epidemiology and Market Forecast - 2034" report provides current treatment practices, emerging drugs, Acute Pain market share of the individual therapies, current and forecasted Acute Pain market size from 2020 to 2034 segmented by seven major markets. The report also offers current Acute Pain therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Acute Pain market.
Request for a sample report @ https://www.delveinsight.com/report-store/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key highlights from the acute pain market report:
The International Association for the Study of Pain (IASP) defines acute pain as sudden, sharp pain signaling a threat or disease. It arises from injury, surgery, illness, trauma, or medical procedures, typically lasting from minutes to less than 6 months and subsiding with treatment or healing.
In 2023, postoperative pain, trauma pain, and acute medical illness accounted for ~40%, ~40%, and ~20% of diagnosed incident cases of acute pain in the United States, respectively.
The market is anticipated to witness a substantial positive shift owing to better uptake of existing drugs, the expected market launch, and raised awareness.
The emerging pipeline of acute pain contains various promising therapies expected to enter the 7MM market during the forecast period (2024-2034).
The United States accounts for the largest market size of Acute Pain, in comparison to EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
In February 2024, AFT Pharmaceuticals disclosed the launch of Maxigesic IV, the intravenous variant of its pain relief medication, in the United States through its licensee, Hikma Pharmaceuticals.
Some of the approved therapies include Hyloris Pharmaceuticals/AFT Pharmaceuticals (MAXIGESIC), Formosa Pharmaceuticals (APP13007), and others.
Emerging Drugs are - Vertex Pharmaceuticals (suzetrigine), Taiwan Liposome Company (ropivacaine liposomal), Vivozon (opiranserin) and others.
DelveInsight's "Acute Pain - Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Acute Pain, historical and forecasted epidemiology as well as the Acute Pain market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Acute Pain market report provides real-world prescription pattern analysis, emerging drugs, market share of individual therapies, and historical and forecasted 7MM Acute Pain market size from 2020 to 2034. The report also covers current Acute Pain treatment practices/algorithms and unmet medical needs to curate the best opportunities and assess the market's underlying potential.

Download sample report @ https://www.delveinsight.com/sample-request/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Acute Pain Overview

Acute pain is a type of pain that arises suddenly in response to a specific injury, illness, or condition and typically lasts for a short period, often less than three to six months. It serves as a protective mechanism, alerting the body to potential harm and prompting individuals to take action to address the cause of the pain.

Causes

Acute pain can result from a wide range of causes, including:

1. Injuries:
- Trauma: Such as fractures, sprains, or cuts.
- Surgical Procedures: Pain following an operation.

2. Medical Conditions:
- Infections: Examples include appendicitis, urinary tract infections, or sinusitis.
- Inflammatory Conditions: Such as rheumatoid arthritis or gout.
- Acute Conditions: Like a heart attack or pancreatitis.

3. Musculoskeletal Issues:
- Muscle Strain: Overuse or injury leading to pain.
- Back Pain: Due to muscle strain or herniated discs.

4. Postoperative Pain:
- Pain After Surgery: Resulting from incisions and tissue manipulation during the procedure.

5. Nerve Pain:
- Nerve Compression: Such as from a herniated disc or carpal tunnel syndrome.

Signs and Symptoms

Symptoms of acute pain can vary depending on the cause and location, but generally include:

- Sharp or Stabbing Pain: Often localized to the area of injury or problem.
- Throbbing or Aching Sensation: Sometimes described as pulsating or aching.
- Tenderness: Sensitivity or pain when touching or applying pressure.
- Swelling or Redness: In cases of inflammation or injury.
- Limited Mobility: Difficulty moving the affected area or joint.
- Other Systemic Symptoms: Such as fever, nausea, or vomiting, depending on the underlying cause (e.g., infection or inflammation).

Diagnosis

Diagnosing the cause of acute pain involves:

1. Clinical Evaluation:
- Medical History: Discussion of the onset, duration, and nature of the pain, along with any associated symptoms.
- Physical Examination: Assessing the affected area for tenderness, swelling, or range of motion limitations.

2. Laboratory Tests:
- Blood Tests: To check for signs of infection, inflammation, or other underlying conditions (e.g., complete blood count (CBC), C-reactive protein (CRP)).

3. Imaging Studies:
- X-rays: To identify bone fractures or joint issues.
- CT Scan or MRI: For more detailed images of soft tissues, bones, and organs, useful in diagnosing conditions like herniated discs or internal injuries.

4. Other Diagnostic Tests:
- Ultrasound: To assess soft tissue injuries or inflammation.
- Electromyography (EMG): To evaluate nerve and muscle function if nerve pain is suspected.

Treatment Options

Treatment for acute pain aims to relieve pain, address the underlying cause, and support recovery:

1. Medications:
- Analgesics: Over-the-counter options like acetaminophen or NSAIDs (e.g., ibuprofen) for pain relief.
- Opioids: For severe pain, used with caution and typically for short-term management.
- Topical Treatments: Creams or patches applied directly to the skin to relieve localized pain.

2. Non-Pharmacological Therapies:
- Rest: Allowing the affected area to heal and avoid exacerbating the injury.
- Ice or Heat: Applying ice to reduce inflammation or heat to relax muscles and improve blood flow.
- Physical Therapy: Exercises and stretches to improve mobility and strengthen muscles.
- Massage: To alleviate muscle tension and improve blood flow.

3. Procedural Interventions:
- Injections: Corticosteroid or nerve blocks to reduce inflammation and pain.
- Surgery: In cases where conservative treatments fail or if there is an underlying condition requiring surgical intervention.

4. Lifestyle and Self-Care:
- Proper Ergonomics: Adopting good posture and body mechanics to prevent strain and injury.
- Pain Management Techniques: Such as relaxation exercises, mindfulness, or cognitive-behavioral therapy (CBT) to manage chronic pain if it persists.

Prognosis

The prognosis for acute pain largely depends on its cause and how effectively the underlying issue is addressed. In many cases, acute pain resolves as the injury heals or the underlying condition improves. However, if acute pain is not properly managed, it may progress to chronic pain, which can significantly impact quality of life. Timely and appropriate treatment is crucial to managing acute pain effectively and preventing potential long-term complications.

Acute Pain Epidemiological Insights
As per the DelveInsight's assessment, in the US, out of the total acute pain cases approximately 38%, 47%, and 15% cases are mild, moderate and severe, respectively
Request for a sample page of our acute pain market report @ https://www.delveinsight.com/sample-request/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Acute Pain Treatment Market
After years of negligence, issues of pain assessment and management have captured the attention of both health care professionals and the public. Factors that prompted such attention include the rapidly increase in the number of patients with pain, continuing evidence that pain is under-treated, and a growing awareness of the adverse consequences of inadequately managed pain. Improved understanding of pain mechanisms has advanced treatment for pain. Sufficient knowledge and resources exist to manage pain in the majority of individuals with acute pain.
In the current scenario, NSAIDs and Opioids are recommended for the treatment, but their over-usage is a major concern, which needs to be addressed. Due to this high number of therapies-all being launched at nearly the same time-there will be a strong race among all these therapies. Therefore, no noteworthy difference in the market shares of these therapies has been observed so far. However, the variation lies in their target population, as well as the therapeutic class of each one of them.
Promising Therapies in the Acute Pain Pipeline
CL-108
NTM-001
Omzya
And others
Discover more about Acute Pain therapies in the pipeline @ https://www.delveinsight.com/sample-request/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Leading Companies Working in the Acute Pain Market
Charleston Laboratories
Neumentum
Neurana Pharmaceuticals
And others
To understand key companies related to the Acute Pain Market, get a snapshot of the Acute Pain Regulatory and Patent Analysis @ https://www.delveinsight.com/sample-request/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Scope of the Acute Pain Market Report
Study Period: 2020-2034
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]
Key Acute Pain Companies: Charleston Laboratories, Neumentum, Neurana Pharmaceuticals, and others
Key Acute Pain Pipeline Therapies: CL-108, NTM-001, Omzya, and others
Therapeutic Assessment: Acute Pain current marketed and emerging therapies
Acute Pain Market Dynamics: Acute Pain market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL's views, Analyst's views, Acute Pain Market Access and Reimbursement

Request for a sample report @ https://www.delveinsight.com/sample-request/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Trending Reports by DelveInsight:

Adalimumab Biosimilar Market | Arbovirus Infection Market | Artificial Pancreas Device System Market | Dental Equipment Market | Gluten Sensitivity Market | Hypothyroidism Market | Inflammatory Bowel Disease Market | Mayus Kinase Jak Inhibitors Market | Mild Dry Eye Market | Mucopolysaccharidosis Market | Oncolytic Virus Cancer Therapy Market | Pyoderma Gangrenosum Market | Transdermal Drug Delivery Devices Market | Intrathecal Pumps Market | Hedgehog Pathway Inhibitors Market | Yellow Fever Market | Laryngeal Cancer Market | Female Infertility Market | Gender Dysphoria Market | Chronic Brain Damage Market | Spain Healthcare Outlook Market | Malignant Fibrous Histiocytoma Market | Asthma Diagnostic Devices Market | Chronic Obstructive Pulmonary Disease Treatment Devices Market | Airway Management Devices Market | Cough Assist Devices Market | Pulse Oximeters Market | Hemodialysis Catheter Devices Market | Chronic Spontaneous Urticaria Market | Gender Dysphoria Market | Germany Healthcare Outlook | Biopsy Devices Pipeline Insight | Bacterial Conjunctivitis Market | Infliximab Biosimilar Insight | Eosinophilic Asthma Market | Cushing Syndrome Market | Functional Dyspepsia Market | Peripherally Inserted Central Catheters (PICC) Devices Market
Table of Contents
1. Acute Pain Market Key Insights
2. Acute Pain Market Report Introduction
3. Acute Pain Market Overview at a Glance
4. Acute Pain Market Executive Summary
5. Disease Background and Overview
6. Acute Pain Treatment and Management
7. Acute Pain Epidemiology and Patient Population
8. Patient Journey
9. Acute Pain Emerging Drugs
10. 7MM Acute Pain Market Analysis
11. Acute Pain Market Outlook
12. Potential of Current and Emerging Therapies
13. KOL Views
14. Acute Pain Market Drivers
15. Acute Pain Market Barriers
16. Unmet Needs
17. SWOT Analysis
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Contact Us:

Kritika Rehani
info@delveinsight.com
+14699457679

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.